EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing

Weifeng Yang, Lv Yao, Lijun Wan, Changshui Zhuang iD

The Journal of Gene Medicine · 2026

DOI: 10.1002/jgm.70108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2026. Verfasst von Weifeng Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Serine-Arginine Splicing Factors, RNA, Circular, RNA Precursors. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Quzhou Project of Science and Technology, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Circular RNAs (circRNAs) represent key regulators in cancer pathogenesis; however, their involvement in alternative splicing (AS) remains poorly understood.

Methods

Expression of circFut8 was detected in bladder cancer ( BC ) tissues/cell lines; RNA pull‐down, cross‐linking immunoprecipitation (CLIP) assays verified circFut8's interaction with splicing factor SRSF9. CircFut8 overexpression was performed to assess its effects on BC cell proliferation in vitro (CCK‐8, colony formation) and tumor growth in vivo (xenograft models), and its modulation of FUT8 pre‐mRNA splicing was analyzed.

Results

Here, we identify circFut8—a conserved exonic circRNA originating from FUT8 gene exon 3—as a BC tumor suppressor, which is significantly downregulated in BC tissues and cell lines, correlating with advanced tumor grade and invasion. Mechanistically, circFut8 competitively binds the splicing factor SRSF9, thereby modulating the inclusion/exclusion of exon 3 in FUT8 pre‐mRNA and promoting the production of the FUT8‐4 splice variant. Functional assays confirm that circFut8 overexpression inhibits BC proliferation in vitro and suppresses tumor growth in vivo, while RNA pull‐down and cross‐linking immunoprecipitation (CLIP) assays confirm its direct interaction with SRSF9.

Conclusions

Our findings unveil a novel circRNA‐mediated regulatory axis wherein circFut8 fine‐tunes pre‐mRNA splicing through competition with SRSF9, suggesting its potential as a candidate for further therapeutic exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsSerine-Arginine Splicing FactorsRNA, CircularRNA PrecursorsRNA SplicingHumansAnimalsCell ProliferationGene Expression Regulation, NeoplasticMiceCell Line, TumorAlternative SplicingFemaleExonsMale

Stichwörter der Autor:innen

SRSF9alternative splicingbladder cancercircFut8

Substanzen

Serine-Arginine Splicing FactorsRNA, CircularRNA PrecursorsSRSF9 protein, human

Autor:innen und Institutionen

  • Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
  • Department of Gynecology and Obstetrics, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

ORCID-Profile: Changshui Zhuang

Förderung

  • Quzhou Project of Science and Technology
  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Yang, W., Yao, L., Wan, L., & Zhuang, C. (2026). CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70108

Vancouver

Yang W, Yao L, Wan L, Zhuang C. CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing. The Journal of Gene Medicine. 2026. doi:10.1002/jgm.70108

BibTeX
@article{Yang2026,
  author = {Yang, Weifeng and Yao, Lv and Wan, Lijun and Zhuang, Changshui},
  title = {CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing},
  journal = {The Journal of Gene Medicine},
  year = {2026},
  doi = {10.1002/jgm.70108}
}
Kostenlos starten →